LaFleur GE - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies.

LaFleur GE, Azzi AG, Schimmel SM, Howard MS. LaFleur GE, et al. Res Social Adm Pharm. 2023 Apr;19(4):610-614. doi: 10.1016/j.sapharm.2022.11.013. Epub 2022 Dec 2. Res Social Adm Pharm. 2023. PMID: 36566098 Free PMC article.

Evaluation of Gabapentin and Pregabalin Use in Hospitalized Patients With Decreased Kidney Function.

Knowles GM, LaFleur GE, Churchwell MD. Knowles GM, et al. Among authors: lafleur ge. J Pharm Technol. 2024 Feb;40(1):30-36. doi: 10.1177/87551225231217906. Epub 2023 Dec 18. J Pharm Technol. 2024. PMID: 38318261

WITHDRAWN: Technology targeting immunocompromised patients for COVID-19 vaccine in community pharmacies.

LaFleur GE, Azzi AG, Schimmel SM, Howard MS. LaFleur GE, et al. Res Social Adm Pharm. 2022 Oct 18:S1551-7411(22)00340-0. doi: 10.1016/j.sapharm.2022.10.004. Online ahead of print. Res Social Adm Pharm. 2022. PMID: 36347749 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters